AI In Pharma Global Market Report 2022 – By Technology (Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning), By Drug Type (Small Molecule, Large Molecules), By Application (Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $4000.00 | Pages : 175 | Published : February 2022 | SKU CODE : h004 | Delivery Time: 2-3 business days | Format :


The AI in pharma market consists of sales of AI in the pharma and related services that use an automated algorithm to perform tasks that traditionally rely on human intelligence. It can be useful in handling data and presenting results that encourage better decision-making and save human efforts, cost, and time. The market consists of revenue generated by artificial intelligence companies, which are applying in the pharmaceutical industry. Only goods and services traded between entities or sold to end consumers are included.

The main technology types of artificial intelligence (AI) in pharma are context-aware processing, natural language processing, querying method, deep learning. Natural language processing is a a branch of artificial intelligence, concerned with giving computers the ability to understand text and spoken words in the same way that humans do. The various drugs produced are small molecule and large molecules that are used for diagnosis, clinical trial research, drug discovery, research and development and epidemic prediction.

The global AI in pharma market size is expected to grow from $934.56 million in 2021 to $1,236.09 million in 2022 at a compound annual growth rate (CAGR) of 32.3%. The change in the AI in pharma market growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2021. The market is expected to reach $3626.24 million in 2026 at a CAGR of 30.9%.

The growing adoption of artificial intelligence (AI) for clinical trials research is driving its demand for AI in pharma market. To bring a new drug to the market takes on an average 10–15 years approximately and half of this time is consumed during the clinical trial phases of the drug development cycle. Hence, using AI models and analytics tools can accelerate the clinical trial phases, perception of diseases, identify suitable cases and key investigators to inform site selection, and support novel clinical study designs. For instance, in January 2020, Pfizer, an American pharmaceutical company, tied up with a biotech startup Insilico Medicine to identify drug targets. With AI tools Pfizer can speed up drug discovery and reduce drug development costs in the drug development processes. Thus, increasing the adoption of AI for clinical trials research is driving AI in pharma market.

Lack of skilled professionals may hamper the growth of AI in pharma market. In 2019, Indeed.com revealed that AI job postings increased 29.1% over the last year and yet, with no uncertainty due to the AI skills gap, searches for AI-related roles decreased by 14.5% over the same period. The shortage of AI skills is seen as a major barrier to the pace of technology’s adoption. In fact, 56% of senior AI professionals thought that a lack of additional, qualified AI workers was the single most important hurdle to be overcome in terms of obtaining the necessary level of AI implementation beyond business operations. Therefore, the lack of skilled professionals may hamper the growth of AI in pharma market.

Companies operating in the AI for the pharma market are introducing new AI tools that will be beneficial for the pharma companies and this is a key trend in AI in pharma market. AI helps in quality control, predictive maintenance, waste reduction, design optimization and process automation. For instance, in September 2019, Novartis and Microsoft announced a multiyear alliance that will leverage data & Artificial Intelligence to transform how medicines are discovered, developed and commercialized. Further, Novartis also established an AI Innovation Lab to empower associates to use AI across their business. Therefore, companies operating in the market are continuously focusing on introducing new technologies to survive in the AI in pharma market.

In April 2021, Charles River Laboratories, an American pharmaceutical company acquired Distributed Bio Inc. for $83 amount. The acquisition will increase success probability of Charles River Laboratories to deliver high quality, readily formattable antibody. Besides, the acquisition will expand the scientific capabilities of Charles River with innovative and large molecule discovery platform. Distributed Bio is a US-based next generation antibody discovery company with superhuman antibody libraries and integrated antibody technologies.

Major players in the AI in pharma market are Novartis, IBM Watson, Microsoft Corporation, Merck, GNS Healthcare., Google, AstraZeneca, Atomwise Inc., Exscientia, Cyclica, NVIDIA Corporation, XtalPi Inc., BenevolentAI, Cloud Pharmaceuticals Inc, BERG LLC, Bayer, Pfizer, Recursion Pharmaceuticals Inc., and Bristol-Myers Squibb.

North America was the largest region in the artificial intelligence in pharma market in 2021. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the AI in pharma market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The global AI in pharma market is segmented -

1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning

2) By Drug Type: Small Molecule, Large Molecules

3) By Application: Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction

    Table Of Contents

    1. Executive Summary

    2. AI in Pharma

    Market Characteristics

    3. AI in Pharma

    Market Trends And Strategies

    4. Impact Of COVID-19 On AI in Pharma

    5. AI in Pharma

    Market Size And Growth

    5.1. Global AI in Pharma

    Historic Market, 2016-2021, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global AI in Pharma

    Forecast Market, 2021-2026F, 2031F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. AI in Pharma

    Market Segmentation

    6.1. Global AI in Pharma

    Market, Segmentation Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Context-Aware Processing

    Natural Language Processing

    Querying Method

    Deep Learning

    6.2. Global AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Small Molecule

    Large Molecules

    6.3. Global AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Diagnosis

    Clinical Trial Research

    Drug Discovery

    Research and Development

    Epidemic Prediction

    7. AI in Pharma

    Market Regional And Country Analysis

    7.1. Global AI in Pharma

    Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    7.2. Global AI in Pharma

    Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8. Asia-Pacific AI in Pharma

    Market

    8.1. Asia-Pacific AI in Pharma

    Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8.3. Asia-Pacific AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    9. China AI in Pharma

    Market

    9.1. China AI in Pharma

    Market Overview

    9.2. China AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    9.3. China AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    10. India AI in Pharma

    Market

    10.1. India AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    10.2. India AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11. Japan AI in Pharma

    Market

    11.1. Japan AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11.2. Japan AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12. Australia AI in Pharma

    Market

    12.1. Australia AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12.2. Australia AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13. Indonesia AI in Pharma

    Market

    13.1. Indonesia AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13.2. Indonesia AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14. South Korea AI in Pharma

    Market

    14.1. South Korea AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14.2. South Korea AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15. Western Europe AI in Pharma

    Market

    15.1. Western Europe AI in Pharma

    Market Overview

    15.2. Western Europe AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15.3. Western Europe AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16. UK AI in Pharma

    Market

    16.1. UK AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16.2. UK AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17. Germany AI in Pharma

    Market

    17.1. Germany AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17.2. Germany AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18. France AI in Pharma

    Market

    18.4. France AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18.5. France AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19. Eastern Europe AI in Pharma

    Market

    19.1. Eastern Europe AI in Pharma

    Market Overview

    19.2. Eastern Europe AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19.3. Eastern Europe AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20. Russia AI in Pharma

    Market

    20.1. Russia AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20.2. Russia AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21. North America AI in Pharma

    Market

    21.1. North America AI in Pharma

    Market Overview

    21.2. North America AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21.3. North America AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22. USA AI in Pharma

    Market

    22.1. USA AI in Pharma

    Market Overview

    22.2. USA AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22.3. USA AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23. South America AI in Pharma

    Market

    23.1. South America AI in Pharma

    Market Overview

    23.2. South America AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23.3. South America AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24. Brazil AI in Pharma

    Market

    24.1. Brazil AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24.2. Brazil AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25. Middle East AI in Pharma

    Market

    25.1. Middle East AI in Pharma

    Market Overview

    25.2. Middle East AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25.3. Middle East AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26. Africa AI in Pharma

    Market

    26.1. Africa AI in Pharma

    Market Overview

    26.2. Africa AI in Pharma

    Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26.3. Africa AI in Pharma

    Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    27. AI in Pharma

    Market Competitive Landscape And Company Profiles

    27.1. AI in Pharma

    Market Competitive Landscape

    27.2. AI in Pharma

    Market Company Profiles

    27.2.1. Novartis

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. IBM Watson

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Microsoft Corporation

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Merck

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. GNS Healthcare.

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The AI in Pharma

    Market

    29. AI in Pharma

    Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3: Global AI in Pharma
  • Market, Segmentation Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 4: Global AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 5: Global AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 6: Global AI in Pharma
  • Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Global AI in Pharma
  • Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Asia-Pacific, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: Asia-Pacific, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: China, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: China, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12: India, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 13: India, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 14: Japan, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 15: Japan, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 16: Australia, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 17: Australia, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 18: Indonesia, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 19: Indonesia, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 20: South Korea, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 21: South Korea, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 22: Western Europe, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 23: Western Europe, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 24: UK, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 25: UK, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 26: Germany, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 27: Germany, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 28: France, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 29: France, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 30: Eastern Europe, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 31: Eastern Europe, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 32: Russia, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 33: Russia, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 34: North America, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 35: North America, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 36: USA, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 37: USA, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 38: South America, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 39: South America, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 40: Brazil, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 41: Brazil, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 42: Middle East, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 43: Middle East, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 44: Africa, AI in Pharma
  • Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 45: Africa, AI in Pharma
  • Market, Segmentation By Application:, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 46: Novartis Financial Performance
  • Table 47: IBM Watson Financial Performance
  • Table 48: Microsoft Corporation Financial Performance
  • Table 49: Merck Financial Performance
  • Table 50: GNS Healthcare. Financial Performance

List Of Figures

Global Big Data Security Market Overview And Prospects – Includes Big Data Security Market Trends
Global Blockchain In Healthcare Market Outlook, Opportunities And Strategies – Includes Blockchain In Healthcare Market Growth
Global Cable Modem Market Size, Forecasts, And Opportunities – Includes Cable Modem Market Share
Global Cloud Security Market Overview And Prospects – Includes Cloud Security Market Segments
Global Enterprise WLAN Market Outlook, Opportunities And Strategies – Includes Enterprise WLAN Industry
Global Managed Security Services Market Size, Forecasts, And Opportunities – Includes Managed Security Services Market Growth
Global Mobile CRM Software Market Outlook, Opportunities And Strategies
Global Computer Vision in Healthcare Market Overview And Prospects
Database Software Market 2021 - By Product Type (Database Maintenance Management, Database Operation Management), By End User (BFSI, IT & Telecom, Media & Entertainment, Healthcare), By Type Of Deployment (Cloud, On-Premise), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Big Data And Analytics Market 2021 - By Analytics Tools (Dashboard & Data Visualization, Self-Service Tools, Data Mining & Warehousing, Reporting), By Deployment Mode (On-Premise, Cloud), By End Use Industry (BFSI, Retail, Manufacturing, IT And Telecom, Government, Healthcare, Utility), By Application (Customer Analytics, Supply Chain Analytics, Marketing Analytics, Pricing Analytics, Spatial Analytics, Workforce Analytics, Risk & Credit Analytics, Transportation Analytics), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
AI In Pharma Market 2021 - By Technology (Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning), By Drug Type (Small Molecule and Large Molecule), By Application (Clinical Trial Research, Drug Discovery, Research And Development), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Fire Detection Equipment Market 2021 - By Product Type (Heat Detectors, Flame Detectors, Smoke Detectors), By End User (Residential, Commercial, Transport, Industrial), By End Use Industry (Banking, Financial Services and Insurance (BFSI), Hospitality and Travel, Healthcare, Transportation and Logistics, Manufacturing, Retail), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Business Processes Outsourcing Market - By Service Type (CRM BPO, HRO BPO, F&A BPO), By End-Use Industry (Financial Services, Retail & Wholesale, Information Technology, Manufacturing, Healthcare), By Automation Type (Automated BPO Services, Manual BPO Services), By Service Provider’s Location (North America, Asia-Pacific, Western Europe, Eastern Europe, Rest Of World), Drivers And Restraints, By Region, Opportunities And Strategies – Global Forecast To 2022
View Report
5G Infrastructure Equipment Market - By Communication Infrastructure (Small Cell, Macro Cell, Radio Access Network (RAN), Distributed Antenna System (DAS)), By Type Of Network Technology (Software Defined Networking (SDN), Network Function Virtualization (NFV), Mobile Edge Computing (MEC), Fog Computing (FC)), And By Region, Opportunities And Strategies – Global Forecast To 2023
View Report
Browser Games Market - By Type (Pay-To- Play, Free-To-Play, Pay-In-Play), And By Region, Major Players, Opportunities And Strategies - Global Browser Games Market Forecast To 2030
View Report
Video Game Software Market - By Type (Browser Games, PC Games, Smart Phone/Tablet Games, Console Games), By Type Of Transaction (Physical, Online/ Microtransaction, Digital), By Type Of Genre (Action, Shooter, Adventure, Role Playing, Strategy, Fighting, Sports, Racing, Others), And By Region, Opportunities And Strategies - Global Video Game Software Market Forecast To 2030
View Report